Infants develop hypertrophic cardiomyopathy in~30% of diabetic pregnancies. We have characterized the effects of glucose on voltage-gated T-type Ca 2ϩ channels and intracellular free calcium concentration, [Ca 2ϩ ] i in neonatal rat cardiomyocytes. We found that T-type Ca 2ϩ channel current density increased significantly in primary culture neonatal cardiac myocytes that were treated with 25 mM glucose for 48 h when compared with those that were treated with 5 mM glucose. Diabetes is one of the most common medical complications seen in pregnancy. Approximately 3-10% of pregnant women have disorders of glucose intolerance (1). This disease affects the fetal cardiovascular system in many ways, both directly and indirectly. The risk for congenital heart disease in infants of diabetic mothers (IDM) is reported to be 5 times higher than in the general population (2). It has been estimated that 30% of IDM have cardiomegaly, only a few of which develop congestive heart failure (1). Diabetic hypertrophic cardiomyopathy has been associated with poor maternal glucose regulation; however, recent studies indicate that cardiac hypertrophy can be attributed to a more complex mechanism possibly including Ca 2ϩ overload (3-5), which may result from an elevated expression of voltage gated Ca 2ϩ channels.
Infants develop hypertrophic cardiomyopathy in~30% of diabetic pregnancies. We have characterized the effects of glucose on voltage-gated T-type Ca 2ϩ channels and intracellular free calcium concentration, [Ca 2ϩ ] i in neonatal rat cardiomyocytes. We found that T-type Ca 2ϩ channel current density increased significantly in primary culture neonatal cardiac myocytes that were treated with 25 mM glucose for 48 h when compared with those that were treated with 5 mM glucose. High-glucose treatment also caused a higher Ca 2ϩ influx elicited by 50 mM KCl in the myocytes. KCl-induced Ca 2ϩ influx was attenuated when nickel was present. Real-time PCR studies demonstrated that mRNA levels of both ␣1G (Ca v 3.1) and ␣1H (Ca v 3.2) T-type Ca 2ϩ channels were elevated after high-glucose treatment. High-glucose also significantly increased ventricular cell proliferation as well as the proportion of cells in the S-phase of the cell cycle; both effects were reversed by nickel or mibefradil. These results indicate that high glucose causes a rise in [Ca 2ϩ ] i in neonatal cardiac myocytes by a mechanism that is associated with the regulation of the T-type Ca Diabetes is one of the most common medical complications seen in pregnancy. Approximately 3-10% of pregnant women have disorders of glucose intolerance (1) . This disease affects the fetal cardiovascular system in many ways, both directly and indirectly. The risk for congenital heart disease in infants of diabetic mothers (IDM) is reported to be 5 times higher than in the general population (2) . It has been estimated that 30% of IDM have cardiomegaly, only a few of which develop congestive heart failure (1). Diabetic hypertrophic cardiomyopathy has been associated with poor maternal glucose regulation; however, recent studies indicate that cardiac hypertrophy can be attributed to a more complex mechanism possibly including Ca 2ϩ overload (3) (4) (5) , which may result from an elevated expression of voltage gated Ca 2ϩ channels.
Two well-documented voltage gated Ca 2ϩ channels found in fetal and neonatal hearts are the L-type and T-type Ca 2ϩ channels (6 -8) . The L-type Ca 2ϩ channels become more abundant as some organisms develop into adulthood (8 -10) ; however, T-type Ca 2ϩ channels are down-regulated or disappear in adult animals (6, (11) (12) (13) (14) . The density of T-type Ca 2ϩ channels is predominant only in pacemaker cells of the sinoatrial node and the Purkinje fibers (15, 16) . The physiologic role of the T-type Ca 2ϩ channel has been postulated to be involved in the cell cycle during proliferation (17) ; therefore, we expect to see an increase in T-type Ca 2ϩ channel activity in glucoseinduced neonatal hypertrophic cardiomyopathy secondary to cell proliferation.
We hypothesized that T-type calcium currents would be increased in response to high glucose. We found that this indeed was the case and that many of the effects of high glucose were prevented by manipulations that reduced T-type calcium currents. (18, 19) . Briefly, hearts were removed and transferred to a 100-mm dish that contained heparin solution (1ϫ Hanks balanced saline solution, 10 mM HEPES, and 10 units of heparin). After hearts were dissected into two pieces with a surgical scalpel, the tissue was washed once with the heparin solution and incubated with gentle rocking in a solution that contained 1ϫ Hanks balanced saline solution, 10 mM HEPES, and 1 mg/mL trypsin, at 4°C, 75 rpm overnight. The next day, tissue was pipetted five times every 2 min with a 10-mL-wide mouth pipette in a solution that contained 1ϫ Hanks balanced saline solution, 10 mM HEPES, and 1 mg/mL collagenase (Sigma Chemical Co., St. Louis, MO), and the supernatant was discarded at each time. Cardiomyocytes were recovered afterward by resuspending in 10 mL of 10% fetal bovine serum (FBS) in M199 medium. Cells were centrifuged at 1000 rpm for 5 min and washed once with cold M199 medium that contained 10% FBS. Fibroblasts were removed by plating (100-mm dishes) cells at 37°C for 45 min in M199 medium that contained 10% FBS. Cardiomyocytes were recovered by collecting the nonadherent cells and cultured in M199 medium that contained 10% FBS, 10 mM HEPES, 2 mM L-glutamine, 0.2 mg/mL vitamin B 12 , 100 units/mL penicillin/streptomycin, and 10 mM glutamine. Cells were plated on tissue culture plates that were precoated with 0.1% gelatin at a density of 5 ϫ 10 5 cells/mL and grown at 37°C in 5% CO 2 . Cardiomyocytes were cultured with standard M199 medium that contained 2% FBS, forming a nearly confluent monolayer by the second day after plating. The next day, the cells were changed to a standard serum-free medium plus 56 U/L insulin, and 5 mM glucose or 25 mM glucose, respectively. After a 48-to 72-h incubation period, cells were studied to determine their electrophysiologic and calcium influx properties.
Electrophysiologic recording. The whole-cell recordings were carried out by the standard "giga-seal" patch clamp technique. The whole-cell recording pipettes were made of hemocapillaries (Warner Instrument Corp., Hamden, CT), pulled by a two-stage puller (PC-10; Narishige Int., New York, NY), and heat polished with a microforge (MF-200; World Precision Instruments, Sarasota, FL) before using. The pipette resistance was in the range of 2-5 M⍀ with our internal solution. The recordings were performed at room temperature (22°C). Currents were recorded using an EPC-9 patch-clamp amplifier (HEKA, Lambrecht/Pfalz, Germany) and filtered at 2.9 kHz. Data were acquired with Pulse/PulseFit software (HEKA). Voltage-dependent currents were corrected for linear leak and residual capacitance by using an on-line P/4 subtraction. Normalized conductance-voltage relationship curves were fitted with the Boltzmann equation, ] i were determined as the fluorescence ratio (R) of the isobestic point for fura-2 (360 nm) to Ca 2ϩ -unbound (380 nm) excitation wavelengths emitted at 510 nm. Reverse transcriptase-PCR. Total RNA was extracted from neonatal cardiac myocytes using the TRIzol reagent method according to the manufacturer's instructions (Life Technologies, Grand Island, NY). First-strand cDNA was made by reverse transcription of 2 g of total RNA from different treatment groups in 50 L of reverse transcription buffer that contained 1.5 M specific primers, 0.5 mM dNTP, 10 M DTT, 100 U of rRNasin (Promega, Madison, WI), and 500 U of M-MLV reverse transcriptase (Life Technologies) at 37°C for 1 h. The reverse transcriptase was inactivated by heating at 99°C for 5 min. PCR was carried out in a solution that contained 2ϫ reaction mix (25 L), SuperScript II RT/Taq Mix (1 L), RNA (3 g), and 10 pmol of Ca v 3.1 or Ca v 1.2 forward and reverse primers (Table 1 ) in a total volume of 50 L. After incubation at 46°C for 30 min, the mixture was run in a thermocycler for 36 cycles. Each cycle consisted of a denaturing at 94°C for 30 s, annealing at 56°C for 30 s, and extension at 68°C for 1 min, sequentially. After reverse transcriptase-PCR (RT-PCR), 10 L of each product was loaded onto a 1% agarose gel for electrophoresis.
Quantitative real-time PCR. RNA was extracted using Trizol method, and cDNA synthesis was carried out using the High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Before cDNA synthesis, total RNA was treated with DNAse I. Two micrograms of total RNA was used in each cDNA synthesis.
Quantitative real-time PCR was performed using SYBR Green PCR Master Mix, and message level was determined using the ⌬⌬ct method. Quantitative real-time PCR was carried out under the following reaction conditions: stage 1, 50°C for 2 min (rep 1); stage 2, 95°C for 10 min (rep 1); and stage 3, 95°C for 15 s then 60°C for 1 min (reps 40). Ca v 3.1 and Ca v 3.2 primer sequences used in the experiment were designed using Primer Express 1.0 and are shown in Table 2 . Experiments were carried out using a Perkin Elmer GeneAmp PCR System 9600 with a GeneAmp 5700 Sequence detector and detection software version 1.3 (Perkin Elmer, Foster City, CA).
Antisense and sense oligonucleotides. T-type Ca 2ϩ channel-specific antisense oligonucleotides were designed against the common motif NMFVGV-VVE of DIIISVI (20) of Ca v 3.1 (accession no. AF027984) and Ca v 3.2 (accession no. AF290213) and purchased from Sequetur (Natick, MA). Cells were transfected with antisense or sense oligonucleotides by TransFast transfection reagent (Promega). Transfection with oligonucleotides was performed according to the manufacturer's instructions. The oligonucleotides were incubated with TransFast reagent for 15 min at room temperature. Myocytes that were cultured for 24 h were washed to remove serum before addition of oligonucleotides-TransFast mixtures, and incubation was performed for 20 h at 37°C. The TransFast solution was removed, M199 culture medium was added, and the myocytes were cultured at 37°C for 48 h before the experiments.
Protein assay and cell count. Cardiomyocyte cellular protein content was measured by using the standard Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). The cells were counted using the Particle Counter (Coulter Corp., Miami, FL).
Flow cytometry. Rat neonatal ventricular myocytes were cultured in the standard serum-free medium (no insulin) for 48 h. This resulted in Ͼ90% of the cardiomyocytes being arrested in the G 0 -G 1 phase. After this process, cells were incubated in the same medium as for electrophysiologic studies, supplemented with 5 or 25 mM glucose or 25 mM glucose plus Ca 2ϩ channel antagonists for 24 h. Cells then were collected with trypsin-EGTA solution and washed three times with PBS (pH 7.4). Collected cells were resuspended in 1 mL of analysis buffer that contained 0.1% sodium citrate, 0.3% NP-40, 0.05 
RESULTS
To investigate the effects of chronic high glucose concentrations on voltage activated Ca 2ϩ currents, we used primary cultured rat neonatal cardiac myocytes that were treated with either 5 or 25 mM glucose for 48 h to evaluate their Ca 2ϩ current amplitudes with whole-cell patch clamp. The Ca 2ϩ currents were elicited with test pulses stepped between Ϫ70 and 40 mV for 100 ms, with 10-mV increments at the membrane holding potential of Ϫ80 mV. The amplitudes of the currents were normalized by the membrane capacitances of the corresponding cells. As shown in Fig. 1C , we found that the current densities at Ϫ30 mV were Ϫ13.6 Ϯ 1.4 pA/pF and Ϫ7.5 Ϯ 0.6 pA/pF in cells that were pretreated (48 h) with 25 and 5 mM glucose, respectively. Figure 1A shows the representative traces of currents measured at Ϫ30 from cells that were treated with 5 mM (upper) and 25 mM (lower) glucose. The increased current densities were also observed at test potentials between Ϫ50 and 0 mV. Because the voltage threshold for T-type Ca 2ϩ current activation was~Ϫ50 mV and the peak current voltage was~0 mV, this suggested that the increases in total Ca 2ϩ current were mainly attributed to an increase in low-threshold Ca 2ϩ currents, or T-type Ca 2ϩ currents. In contrast, the current densities at the voltages positive than 0 mV had fewer differences between the groups that were treated with 5 and 25 mM glucose, indicating that L-type Ca 2ϩ currents remained at approximately the same levels. This observation was further confirmed with selectively recording of L-type Ca 2ϩ current at 20 mV with holding potential of Ϫ40 mV, at which most of the T-type Ca 2ϩ currents were inactivated. Figure 1B shows two representative traces of L-type Ca 2ϩ current with similar amplitudes from the cells that were treated with 5 mM (upper) or 25 mM (lower) glucose for 48 h, respectively. Increasing the osmotic strength of the normal glucose solution with 20 mM mannitol had no effect on the T-type current density (Fig. 1C) .
Chronic high glucose-induced increases in current densities measured at low voltages might also be due to the shift of voltage-dependent activation or inactivation of the T-type Ca 2ϩ currents. To examine this possibility, we characterized the voltage-dependent activation and steady-state inactivation of the T-type Ca 2ϩ current in the cells that were pretreated with 5 or 25 mM glucose. The voltage-dependent T-type Ca 2ϩ conductance was determined by measuring the amplitudes of slow decaying tail currents at Ϫ120 mV (200 ms) preceded by a 20-ms testing pulse stepped from Ϫ60 mV to 50 mV (10 mV increments). The steady-state inactivation of T-type Ca 2ϩ current was determined by measuring the inactivation of the current elicited at Ϫ30 mV after 3-s prepulses ranging from Ϫ100 to Ϫ30 mV. With our external solution that contained 10 mM Ca 2ϩ , currents at Ϫ30 mV were mainly attributed to T-type Ca 2ϩ currents because the currents were completely inactivated when a prepulse of Ϫ40 mV was applied (Fig. 1D ). Data were calculated and fitted with the Boltzmann equation.
As shown in Fig. 1D , the T-type Ca 2ϩ currents were activated initially at Ϫ50 mV and completely inactivated by a prepulse at Ϫ40 mV. Pretreating the cells with 25 mM glucose for 48 h did not change the characteristics of either the voltagedependent activation or steady-state inactivation of T-type Ca 2ϩ currents (Fig. 1D ).
To selectively block T-type currents in neonatal cardiac myocytes, we examined the effect of a T-type Ca 2ϩ channel Voltage-dependent activation (G) and steady-state inactivation (I) curves of T-type Ca 2ϩ currents from cells that were treated with 5 or 25 mM glucose. The normalized G was plotted as a function of test pulse voltage. The activation data were obtained by measuring the tail current at Ϫ100 mV after the stimulation pulses stepped from Ϫ60 to 50 mV with a holding potential of Ϫ80 mV. The inactivation data were generated with a protocol that consisted of 3-s prepulses ranging from Ϫ100 to Ϫ25 mV followed immediately by a test pulse (100 ms) to Ϫ30 mV. Both activation and inactivation data were normalized to the maximum of the functions and fitted to the Boltzmann equation. Open symbols represent the data from 5 mM glucose-treated cells (con), and closed symbols represent the data from 25 mM glucose-treated cells (glu). [V 1/2 ϭ (glu) Ϫ19.4 mV, (con) Ϫ21.7 mV, k ϭ (glu) Ϫ10.8, (con) Ϫ7.8, n ϭ (high glucose) 8, (con) 5, for activation curves; V 1/2 ϭ (high glucose) Ϫ59.5 mV, (con) Ϫ57.9 mV, k ϭ (glu) 4.3, (con) 4.9, n ϭ (glu) 8, (con) 8, for inactivation curves].
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blocker, nickel (50 M NiCl 2 ), on the T-and L-type Ca 2ϩ currents in myocytes that were pretreated with 25 mM glucose. In these experiments, T-type Ca 2ϩ currents were selectively inhibited by NiCl 2 , which was demonstrated by measuring the slow-decaying tail currents before and after NiCl 2 administration ( Fig. 2A) . Nickel had no effect on the L-type Ca 2ϩ currents that were selectively recorded at a test potential of 20 mV when held at Ϫ40 mV with an external solution that contained 40 mM Ba 2ϩ (Fig. 2B) . Because nickel selectively reduced T-type Ca 2ϩ tail-current density by 51%, whereas its effect on L-type Ca 2ϩ current was minimal (Fig. 2C) ] elevation elicited by 50 mM KCl as shown in Fig. 3 . The Ca 2ϩ influxes were reduced when 50 M NiCl 2 was added to the bath solution (Fig. 3C) (21) , and an L-type Ca 2ϩ channel isoform, Ca v 1.2. Each RT-PCR product was sequenced and matched to known sequences. The result indicated that 25 mM glucose induced an increase in mRNA level of the Ca v 3.1 channel after 1, 6, 12, and 24 h of treatment when compared with the paired 5-mM glucose incubation groups (Fig. 4A) . In contrast, no significant difference in mRNA levels of the Ca v 1.2 was observed between the low glucose-and high glucose-treated groups for 2, 12, and 34 h (Fig. 4B) . Similar results were obtained from three repeated experiments. These results indicated that a high concentration of glucose upregulated T-type Ca 2ϩ channel but not L-type Ca 2ϩ channel mRNA expression in rat neonatal cardiomyocytes. 
T-CHANNEL AND CARDIOMYOCYTE PROLIFERATION
We also used real-time PCR technology to quantitatively measure the level of high glucose-regulated Ca v 3.1 and Ca v 3.2 (22) mRNA expression. When neonatal cardiomyocytes were treated with 25 mM glucose for 1, 6, 12, 24, and 48 h, we found larger increases of mRNA levels of T-type Ca 2ϩ channels at early time points (1 and 6 h) and a smaller but sustained elevation of both mRNA levels for longer time points (Fig.  4C) .
Because high-concentration glucose increases T-type Ca 2ϩ channel current expression and voltage-dependent Ca 2ϩ influx, it is important to learn the role of these channels in neonatal cardiomyocyte proliferation. We used antisense and sense oligonucleotides against both Ca v 3.1 and Ca v 3.2 T-type Ca 2ϩ channels to selectively inhibit the function of T-type Ca 2ϩ channels. The inhibitory effect of the antisense oligonucleotides on T-type Ca 2ϩ currents has been confirmed in neurons previously (20) . We further tested the effects of these oligonucleotides on T-and L-type Ca 2ϩ channel activities, respectively. Current densities in the cells that were treated with sense or antisense oligonucleotides for 48 h were recorded with voltage protocols that were selective to T-or L-type channels. Figure 5A shows that the current density measured at Ϫ30 mV with holding potential of Ϫ80 mV, which predominantly records T-type Ca 2ϩ currents, was significantly suppressed in the Ca v 3.1/Ca v 3.2 antisense oligonucleotide-treated cells when compared with the cells that were treated with the sense oligonucleotides. In contrast, no significant difference was observed in these cells when the current densities were measured at 20 mV with holding potential of Ϫ40 mV, which exclusively records L-type Ca 2ϩ currents (Fig. 5B) . These results suggest that the antisense oligonucleotides selectively and effectively reduced T-type Ca 2ϩ channel currents in neonatal cardiomyocytes. Cellular proliferation was monitored by measuring [ 3 H]thymidine incorporation in rat neonatal cardiomyocytes. The cells were transfected with either antisense or sense oligonucleotides for 48 h. At the last 4 h, 2 Ci of [ 3 H]thymidine was added into the culture medium. We found that the antisense oligonucleotides suppressed [ 3 H]thymidine incorporation significantly when compared with that transfected with sense oligonucleotides (Fig. 5C ). These data suggest that T-type Ca 2ϩ channels play an important role in rat neonatal cardiomyocyte proliferation.
To reveal the mechanism by which T-type Ca 2ϩ channels affect neonatal cardiomyocyte proliferation, we investigated the pharmacologic effect of T-type Ca 2ϩ channel antagonists on the phase distribution of the cell cycles. Flow cytometric technique was used to determine the proportion of cells in different phases of the cell cycle. High-glucose (25 mM) treatment profoundly increased the percentage of cells in the S phase as seen in Fig. 6 , whereas the presence of 50 M NiCl 2 or 1 M mibefradil, another Ca 2ϩ channel antagonist (23), effectively reversed this effect. In contrast to high glucose alone, the L-type Ca 2ϩ channel antagonist nifedipine (10 M) did not have a significant effect on the proportion of cells in S-phase. These results suggested that high glucose caused an increase in DNA synthesis in cultured rat neonatal ventricular myocytes and that T-type Ca 2ϩ channels play an important role before or during the S-phase of mitosis.
Is increased expression of T-type Ca 2ϩ currents and correspondingly increased Ca 2ϩ influx involved with high glucoseinduced hyperplasia? We addressed this question by examining the effect of nickel on the total number of cells and total protein content of cells that were treated with high glucose. We found that 25-mM glucose treatment substantially increased cell number until the culture was confluent. This effect was reversed when 50 M nickel was included in the growth medium (Fig. 7A) . However, high-glucose treatment did not affect total protein content (Fig. 7B) . This result indicated that high concentration of glucose promoted an increase in rat neonatal cardiomyocyte proliferation but not cell hypertrophy via a T-type Ca 2ϩ channel activity-dependent mechanism. The notion that lack of hypertrophic effect of high-glucose treatments is also supported by the capacitance measurement of individual cells that underwent whole-cell recording, because the membrane capacitance is proportional to the surface area of the cells. We found no significant difference in the membrane capacitances between the low glucose-(26.6 Ϯ 3.9 pF, n ϭ 44) and high glucose-treated groups (30.1 Ϯ 6.7 pF, n ϭ 21; p Ͼ 0.5). This supported the hyperplasia not the hypertrophy mechanism.
DISCUSSION
It has been reported that T-type Ca 2ϩ channels were upregulated in an experimental model of cardiac hypertrophy and were involved in myocardial remodeling (24) . In the heart, T-type Ca 2ϩ channels can be induced by angiotensin II (25) or endothelin-1 (26); here, we report that high concentration of glucose might also induce the messenger level of these channels in rat neonatal cardiomyocytes.
The purpose of this study was to investigate the pathophysiologic role of T-type Ca 2ϩ channels in high glucose-induced myocardial hypertrophy in neonatal rat heart. Because T-type Ca 2ϩ channel current is more prevalent during the embryonic, fetal, and neonatal periods and disappears during maturation into adulthood, it has been postulated that the T-type Ca 2ϩ channel is important in the maturation/differentiation process. In primary cultured rat aortic smooth muscle cells, a T-type Ca 2ϩ current was present in cells during the G 1 and S phase but decreased or was absent in all other phases of cell division (27) . It was shown that cultured smooth muscle cells had an increased T-type Ca 2ϩ current during proliferation, and this current decreased as the cells became confluent or when they came in contact with each other (28) . In our study, T-type Ca 2ϩ current density was significantly greater in high glucosetreated cells compared with controls, which indicated that these channels might play an important role in proliferation, particularly in the S phase of cell cycle in cardiomyocytes.
Transient increases in [Ca 2ϩ ] i has been reported to be essential in the progression through specific stages of the cell cycle in different mammalian cells (29) . The machinery underlying calcium effects may involve many intracellular signal pathways, such as G protein, protein kinase C, calmodulin, m-calpain, mitogen-activated protein kinase, cyclin-dependent kinase 2, phosphatases, and others (30 -33) . In addition, Ca 2ϩ influx may directly or indirectly alter the plasma membrane potential, which is a critical factor for cell cycling (34) . T-type Ca 2ϩ currents may contribute to the modulation of calcium homeostasis in these cells. Our results suggest that high glucose induced an overexpression of T-type Ca 2ϩ channels, which increases the proliferation rate of neonatal cardiomyocytes.
IDM have a higher rate of congenital anomalies than the general population. Many IDM have a thickened interventricular septum and wall. The most frequent defects are congenital 
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T-CHANNEL AND CARDIOMYOCYTE PROLIFERATION heart diseases, including hypertrophic cardiomyopathy (35) , which has been linked to gestational diabetes of the women (36) . In this study, we report data supporting the concept that these defects are directly correlated to poor maternal metabolic control. More specific, the regulation of T-type Ca 2ϩ channels by high glucose reported in this study may represent an important pathologic process of hypertrophic cardiomyopathy seen in IDM. Our results suggest that control of plasma glucose concentration in diabetic mothers may play an effective role in prevention or treatment of these cardiac abnormalities in IDM.
Nickel has been shown previously to have toxic effects on cells after a 24-h incubation period with concentrations higher than 100 M (37). We have previously shown that high concentrations (100 M or more) of nickel also block L-type Ca 2ϩ channels (38) ; for these reasons, we chose to use a relatively low concentration (50 M) of nickel in our experiments. It has been shown that the T-type Ca 2ϩ currents in the cardiomyocytes of rat and guinea pig are sensitively blocked by nickel at a similar concentration (40 M) to that used in our study (39, 40) . It is known that Ca v 3.2 is highly sensitive to nickel (41) . The nickel effect seen in our and others' studies using cardiomyocytes might be mainly attributed to its effect on the Ca v 3.2 Ca 2ϩ channel, which plays an important role in the cardiomyocyte function. However, the role of Ca v 3.1 might also be considered because it has been shown that a Ca v 3.1 splicing isoform (Ca v 3.1d) expressed in the developing heart can be half blocked by 100 M NiCl 2 (42) . Our data show that T-type Ca 2ϩ channels contribute significantly to the cardiomyocyte proliferation.
